Scaling-up remains a complex and often underestimated challenge across the microbial manufacturing development lifecycle. While many microbial programs can progress successfully at early stages, delays and complications often emerge later as assets move toward late clinical or commercial manufacturing. Challenges are rarely the result of isolated technical failures; pressure points often become most visible at key inflection moments.
This webinar explores five critical scale-up principles observed across high-performing microbial programs, drawing on industry insights from early development through late-stage and commercial readiness. Highlights include:
Where scale-up risks most commonly emerge, and how to recognize these pressure points early.
The difference between a process that performs well today and one that is truly robust, scalable, and defensible as programs progress.
How and why analytics, process understanding, and comparability need to evolve with scale.